{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:26:57Z","timestamp":1779251217173,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clinre.2016.12.007","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T18:00:31Z","timestamp":1487268031000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome"],"prefix":"10.1016","volume":"41","author":[{"given":"Zheng-Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinre.2016.12.007_bib0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/nmo.12292","article-title":"Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis[J]","volume":"26","author":"Atluri","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.clinre.2016.12.007_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gtc.2005.02.008","article-title":"Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors[J]","volume":"34","author":"Cremonini","year":"2005","journal-title":"Gastroenterol Clin North Am"},{"issue":"10","key":"10.1016\/j.clinre.2016.12.007_bib0155","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.molmed.2009.08.001","article-title":"Irritable bowel syndrome: towards biomarker identification[J]","volume":"15","author":"Clarke","year":"2009","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.clinre.2016.12.007_bib0160","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process[J]","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clinre.2016.12.007_bib0165","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders[J]","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl. 2","key":"10.1016\/j.clinre.2016.12.007_bib0170","first-page":"I43","article-title":"Functional bowel disorders and functional abdominal pain[J]","volume":"45","author":"Thompson","year":"1999","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.clinre.2016.12.007_bib0175","doi-asserted-by":"crossref","first-page":"i41","DOI":"10.1136\/gut.51.suppl_1.i41","article-title":"A role for inflammation in irritable bowel syndrome?[J]","volume":"51","author":"Barbara","year":"2002","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clinre.2016.12.007_bib0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2982.2007.01079.x","article-title":"GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome[J]","volume":"20","author":"Hellstrom","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.clinre.2016.12.007_bib0185","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1172\/JCI942","article-title":"Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin[J]","volume":"102","author":"Tolessa","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.clinre.2016.12.007_bib0190","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jcem.87.7.8584","article-title":"Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor[J]","volume":"87","author":"Brubaker","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clinre.2016.12.007_bib0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2982.2009.01442.x","article-title":"Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort[J]","volume":"22","author":"Manabe","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.clinre.2016.12.007_bib0200","doi-asserted-by":"crossref","first-page":"G120","DOI":"10.1152\/ajpgi.00076.2012","article-title":"Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome[J]","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.clinre.2016.12.007_bib0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2036.2008.03870.x","article-title":"Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study[J]","volume":"29","author":"Hellstrom","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clinre.2016.12.007_bib0210","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.cgh.2015.06.022","article-title":"Efficacy of a Chinese herbal medicine in providing adequate relief of constipation-predominant irritable bowel syndrome: a randomized controlled trial[J]","volume":"13","author":"Bensoussan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2016.12.007_bib0215","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome[J]","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2016.12.007_bib0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1748-1716.2010.02150.x","article-title":"GLP-1 playing the role of a gut regulatory compound[J]","volume":"201","author":"Hellstrom","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"10.1016\/j.clinre.2016.12.007_bib0225","first-page":"349","article-title":"Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity[J]","volume":"65","author":"Yang","year":"2014","journal-title":"J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.clinre.2016.12.007_bib0230","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1572-0241.2004.30509.x","article-title":"Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome[J]","volume":"99","author":"Chey","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"11\u201312","key":"10.1016\/j.clinre.2016.12.007_bib0235","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2009.04144.x","article-title":"Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale[J]","volume":"30","author":"Spiegel","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clinre.2016.12.007_bib0240","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1365-2982.2010.01554.x","article-title":"Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis[J]","volume":"22","author":"Edholm","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2016.12.007_bib0245","first-page":"319","article-title":"Glucagon-like peptide-1 gastrointestinal regulatory role in metabolism and motility[J]","volume":"84","author":"Hellstrom","year":"2010","journal-title":"Vitam Horm"},{"issue":"1\u20133","key":"10.1016\/j.clinre.2016.12.007_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.regpep.2012.08.009","article-title":"Receptor-mediated inhibition of small bowel migrating complex by GLP-1 analog ROSE-010 delivered via pulmonary and systemic routes in the conscious rat[J]","volume":"179","author":"Hellstrom","year":"2012","journal-title":"Regul Pept"},{"issue":"1","key":"10.1016\/j.clinre.2016.12.007_bib0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/JOE-13-0525","article-title":"Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle[J]","volume":"221","author":"Amato","year":"2014","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.clinre.2016.12.007_bib0260","doi-asserted-by":"crossref","first-page":"G924","DOI":"10.1152\/ajpgi.2000.278.6.G924","article-title":"Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats[J]","volume":"278","author":"Gulpinar","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.clinre.2016.12.007_bib0265","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2982.2004.00628.x","article-title":"Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39)[J]","volume":"17","author":"Ayachi","year":"2005","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl. 2","key":"10.1016\/j.clinre.2016.12.007_bib0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0025-7753(14)70107-1","article-title":"[Safety and tolerability of GLP-1 receptor agonists][J]","volume":"143","author":"Soldevila","year":"2014","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.clinre.2016.12.007_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S55944","article-title":"an evidence-based review of its potential in the treatment of type 2 diabetes[J]","volume":"10","author":"Edwards","year":"2015","journal-title":"Core Evid"},{"issue":"1\u20132","key":"10.1016\/j.clinre.2016.12.007_bib0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autneu.2006.06.007","article-title":"Glucagon-like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats[J]","volume":"131","author":"Nakade","year":"2007","journal-title":"Auton Neurosci"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117300062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740117300062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:36Z","timestamp":1761895596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740117300062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2210740117300062"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2016.12.007","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}